ClinicalTrials.gg
RecruitingNCT07630467VIDEOPREHOSPUpdated Jun 5, 2026

Pilot Study on the Use of Video Laryngoscopy in Pre-hospital Settings

An interventional study of Videolaryngoscopy in first attempt in prehospital with AirTraq in Emergency and Orotracheal Intubation, sponsored by Centre Hospitalier de Valenciennes. Recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-06-05.

Primary conditionnone(registry's first term: Emergencies)No conditionIs this wrong?Emergencies describes something many studies share rather than a condition a study is about. The study names no condition we can place it under, so it is not compared with other studies by condition.

Sponsored by Centre Hospitalier de Valenciennes · Not applicable, Interventional, and Other

How we know

From the registry’s dates

  • Started Jan 2026; still recruiting 10 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
143
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

Management of the upper airways is an essential skill in pre-hospital medicine in order to protect the respiratory tract and optimise ventilation and oxygenation. Orotracheal intubation remains the gold standard method in this context. In France, approximately 8% of primary SMUR interventions require intubation, representing 40,000 to 50,000 procedures per year, 30 to 40% of which are performed on patients in cardiorespiratory arrest.

Despite an overall success rate of nearly 99%, 8 to 15% of intubations are considered difficult and the success rate on the first attempt is only 77.8%. Difficult intubations expose patients to significant complications, including desaturation (nearly 50% of cases), haemodynamic disorders and, more rarely, cardiopulmonary arrest (3% of cases). Pre-hospital conditions (environment, access to the patient, trauma, secretions, etc.) increase these risks. As a result, recent recommendations now consider any emergency intubation outside the operating theatre to be potentially difficult.

The introduction of video laryngoscopy represents a major technological advance. Its superiority has been demonstrated in hospital settings, particularly for difficult intubations, and it is now recommended as the first-line treatment in this context. However, unlike in the United States, where several studies suggest that it is safer and more effective than direct laryngoscopy, there are no specific recommendations or French studies concerning its use in pre-hospital medicine.

Given these factors and the lack of national data, it seems appropriate to conduct an exploratory French study to assess the place, effectiveness, benefits and constraints of video laryngoscopy in a pre-hospital setting. Investigator hypothesises that the success rate for the first attempt at intubation using video laryngoscopy will be 74%.

Read the detailed description

This is a single-arm exploratory interventional study conducted at the Valenciennes Hospital Centre.

Firstly, practical training in video laryngoscopy has already been provided by Dr GOZE to doctors participating in the SMUR (mobile emergency and resuscitation service) at the Valenciennes Hospital Centre. In Appendix 1, the training certificates of the doctors who submitted their CVs during the initial application process have been included in the protocol. Any investigator wishing to participate in the study and include patients will be required to undergo training and submit an application to the CPP. A presentation of the study will also be given to practitioners.

Before the study is conducted, an explanatory sheet will be given to each practitioner, along with a questionnaire concerning their practice and experience of video laryngoscopy intubation.

From the start of the study, once authorisation has been granted by the CPP, all out-of-hospital intubations will be performed as a first-line treatment using a video laryngoscope, as required by the research protocol. If intubation fails on the first attempt, the practitioner will be free to choose whether to continue with the intubation technique of their choice.

A results sheet will be completed by the operator after each procedure. The results recorded will be: the outcome of the first intubation attempt (success or failure), and the criteria corresponding to the secondary criteria described above.

02

Conditions studied

  • Emergency
  • Orotracheal Intubation

Browse trials for

Keywords

  • orotracheal intubation
  • pre-hospital
  • first attempt
  • videolaryngoscopy
03

In context

Lead sponsor

Centre Hospitalier de Valenciennes is the lead sponsor of 15 studies on the registry; 9 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Patient Inclusion Criteria:

  • Age > 18 years
  • Patients treated pre-hospital by a team from the Emergency Medical and Resuscitation Service (SMUR) at Valenciennes Hospital 2025-A02374-45_SUMMARY_v1.1 dated 04/12/2025 _VIDEOPREHOSP Page 3 of 4
  • Patients whose condition requires pre-hospital orotracheal intubation
  • Patient or relative who has given consent for inclusion
  • Patient affiliated with a social security scheme

Pratician Inclusion Criteria :

  • Practitioner at Valenciennes Hospital
  • Practitioner who is part of the EMS team

Exclusion Criteria:

  • Progressive pregnancy
  • Theoretical indication for orotracheal intubation but patient refuses invasive care, considered in this situation to be futile medical care
  • Insurmountable anatomical obstacle, in which case an emergency cricothyroidotomy or tracheotomy should be considered as the of treatment
  • Patients under guardianship or curatorship
  • Patients deprived of their liberty by court order
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Line of therapy

A line of therapy is one course of treatment, which may combine several drugs. First-line is the first course given; second-line follows when that stops working or is not tolerated.

“Two prior lines” means two courses that count separately under the study’s rules — not simply two drugs. Ask the study team if you are unsure how yours are counted.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
143 participants (estimated)

Study arms

  • Experimental
    Experimental arm

    All patients in a pre-hospital emergency situation for whom videolaryngoscopy was performed on the first attempt.

    Device: Videolaryngoscopy in first attempt in prehospital with AirTraq

Interventions

  • DeviceVideolaryngoscopy in first attempt in prehospital with AirTraq

    This is a single-centre study conducted at Valenciennes Hospital. Eligible patients will be those requiring intubation in a life-threatening emergency as part of standard care. During each SMUR intervention, patients will be assessed to determine their eligibility for the study, according to the inclusion and exclusion criteria previously defined in the protocol. This verification will be carried out by the practitioner in charge of pre-hospital care, before the intubation procedure is performed. The clinical data required for this assessment will be collected prospectively.

06

What researchers measure

Primary outcomes

  1. The main objective of this exploratory study is to estimate the success rate of the first attempt at pre-hospital video laryngoscopy intubation.

    The primary endpoint is the success rate of intubation on the first attempt. The endpoint analysed will be a binary measure (success: 1 / failure: 0) collected during the procedure.

    Time frame: immediately after orotracheal intubation

Secondary outcomes

  1. Secondary objective N°1 : To study the correlation between patient-related constraints in the use of video laryngoscopy and the success/failure of the first intubation attempt.

    The aim is therefore to study the main variable (success or failure of intubation on the first attempt) in relation to different variables that have different units of measurement. Constraints encountered during intubation related to the patient: * Mouth opening: \< 2 cm, between 2 and 3.5 cm, \> 3.5 cm * Thyro-mental distance: \< 5 cm, between 5 and 6.5 cm, \> 6.5 cm * Cormack score: I/II, III/IV * Obesity (BMI \> 30): Yes/No * Presence of secretions in the upper airways: Yes/No * Presence of cervical-facial trauma: Yes/No

    Time frame: immediately after orotracheal intubation

  2. Secondary outcome N°2 : To investigate the correlation between the constraints of using video laryngoscopy in an out-of-hospital setting and the success/failure of the first intubation attempt

    The aim is therefore to study the main variable (success or failure of intubation on the first attempt) in relation to different variables that have different units of measurement. Constraints encountered during intubation, related to the practitioner: * Years of experience as an emergency physician * Number of successful intubations using video laryngoscopy: \< 15, between 15 and 50, \> 50

    Time frame: immediately after orotracheal intubation

  3. Secondary objective N°3 : To investigate the correlation between the constraints of using video laryngoscopy in an out-of-hospital setting and the success/failure of the first intubation attempt

    The aim is therefore to study the main variable (success or failure of intubation on the first attempt) in relation to different variables that have different units of measurement. Constraints encountered during intubation in an out-of-hospital setting: * Patient position: On the ground or on a stretcher * Practitioner position: Lying down, kneeling, or standing * Bright light interfering with visibility on the video laryngoscope: Yes or No

    Time frame: Immediately after video laryngoscopy

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Jan 2026 (actual). Primary completion is estimated for Dec 2026, 11 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 6, 2026
First posted
Jun 5, 2026
StartActual
Jan 2, 2026
Primary completionEst.
Dec 2, 2026
CompletionEst.
Dec 2, 2026
Last update
Jun 5, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 5, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07630467
Lead sponsor
Centre Hospitalier de Valenciennes
Responsible party
Sponsor
First posted
Jun 5, 2026
Start date
Jan 2, 2026
Primary completion
Dec 2, 2026 (estimated)
Completion
Dec 2, 2026 (estimated)
Last update
Jun 5, 2026

Study contacts

Alexandre ANDRIES, MD
Contact
andries-a@ch-valenciennes.fr
06.22.16.79.16

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion